November 30, 2025

Scientists Demonstrate the Tremendous Promise of AI and Machine Learning for Predicting Stroke And Other Neurological Disorders

Identifying acute stroke remains one of the toughest challenges facing emergency medicine and neurology. Traditional stroke alert systems register false positive results in up to two-thirds of cases, resulting in inefficient utilization of costly resources and delays in appropriate care for both stroke and non-stroke patients.

Mount Sinai New York

November 27, 2025

Inside the Race to Detect Neurodegenerative Disease Early

Unlocking a new frontier in diagnosing and understanding complex brain diseases long before symptoms appear

The Pathologist

November 26, 2025

This Week’s Biopharma News: Texas Takes on BMS and Sanofi

This week’s news roundup reports on Texas’s claim against BMS and Sanofi, AstraZeneca’s Maryland investment, Novo Nordisk’s difficult semaglutide admission, and more.

The Medicine Maker

November 20, 2025

Vorasidenib in IDH1/2-Mutant Low-Grade Glioma

As reported in The Lancet Oncology by Cloughesy et al, vorasidenib was associated with improvement in some secondary and exploratory outcomes vs placebo in the phase III INDIGO trial in patients with ...

The ASCO Post

November 19, 2025

FDA Approves Selumetinib for Adults With NF1 With Symptomatic, Inoperable Plexiform Neurofibromas

The MEK inhibitor was approved today for adults with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas. In September 2025, the FDA approved selumetinib capsules a...

The ASCO Post

November 12, 2025

Taking on the Genetic Nonsense with tRNAs

Engineered tRNAs are redefining precision RNA therapeutics, restoring protein function in diseases caused by nonsense mutations, and bridging the gap between RNA and gene editing technologies.

The Medicine Maker

November 11, 2025

Advancing Gene Therapy for Canavan Disease

Interim results from a clinical trial addressing a fatal brain matter disorder suggest that gene therapy could be an effective approach

The Medicine Maker

October 30, 2025

Summarizing the Big Events in the Small Molecules Field

October 2025 highlights in the small molecules sector include developments in dermatitis treatment, improvements in epilepsy symptoms, and the effects of amoxicillin availability.

The Medicine Maker

October 29, 2025

Linking Neurocognitive Outcomes and Advanced Techniques in Awake Glioma Surgery

Glioma surgery in eloquent brain regions remains one of the greatest challenges in neurosurgery, demanding a balance between oncologic control and preservation of function.

Baptist Health South Florida